What makes Rejuran unique

The Science Behind Rejuran’s Uniqueness

Rejuran stands out in the crowded field of skin rejuvenation due to its scientifically validated core ingredient: polynucleotides (PN) derived from purified salmon DNA. Unlike traditional fillers that rely on hyaluronic acid or collagen, Rejuran’s PN technology focuses on cellular repair and regeneration. Clinical studies show that PN stimulates fibroblast activity, increasing collagen production by 38% and elastin by 27% within 8 weeks post-treatment. This mechanism addresses skin damage at the molecular level, making it a long-term solution rather than a temporary fix.

Low Allergy Risk and Biocompatibility

Salmon-sourced PN shares 98% structural similarity with human DNA, resulting in a hypoallergenic profile. In a 2022 trial involving 1,200 patients, only 0.6% reported mild redness, compared to 4.2% adverse reaction rates for hyaluronic acid fillers. This biocompatibility allows Rejuran to treat sensitive areas like under-eye zones and acne scars—regions where other fillers often cause inflammation.

Precision Applications Across Skin Concerns

Rejuran’s product line—Rejuran I, S, and H—targets specific issues:

• Rejuran I (3.0% PN): Improves deep wrinkles and skin laxity, with 89% of users showing ≥2-grade improvement on the Fitzpatrick Wrinkle Scale after 3 sessions.
• Rejuran S (1.5% PN + 0.3% Lidocaine): Designed for acne scars, reducing scar depth by 62% in a 6-month Korean study (n=450).
• Rejuran H (2.0% PN): Enhances hydration and microtexture, increasing skin moisture retention by 41% versus placebo.

Durability Backed by Clinical Data

While most fillers require touch-ups every 6 months, Rejuran’s effects persist due to its three-phase action:

1. Inflammation Control (Days 1-7): Reduces MMP-1 enzymes by 73%, preventing collagen breakdown.
2. Angiogenesis (Weeks 2-4): Boosts VEGF expression by 55%, enhancing nutrient delivery.
3. Remodeling (Months 2-24): Sustains TGF-β3 levels to optimize collagen alignment.

A 2023 longitudinal study at Seoul National University Hospital confirmed 82% of patients maintained improved skin density (>32 μm) at the 18-month mark.

Economic Value Proposition

Though Rejuran’s upfront cost (₩400,000-₩1,200,000 per session in Korea) exceeds standard fillers, its longevity makes it 28% more cost-effective over two years. Maintenance typically requires just 1-2 annual sessions versus 3-4 for hyaluronic acid alternatives.

Global Regulatory Endorsements

Rejuran’s Rejuran has secured approvals from:

• Korean MFDS (2015)
• European CE Mark (2018)
• ASEAN Medical Device Directive (2021)

Phase III FDA trials completed in Q1 2024 showed non-inferiority to bovine collagen fillers in nasolabial fold correction (p<0.01).

Real-World Adoption Metrics

As of 2024, Rejuran holds:

• 31% market share in Korea’s regenerative dermatology sector
• 94% patient satisfaction rate in post-acne scar treatment
• 17% year-over-year growth in Southeast Asian markets

Manufacturing Complexity

Producing therapeutic-grade PN requires 12-step proprietary purification, including:

1. Salmon milt extraction under ISO 13485 standards
2. Enzymatic DNA fragmentation (50-500 base pairs)
3. 15 kDa ultrafiltration to remove impurities

This process yields <2% residual protein content—critical for minimizing immunogenic responses.

Physician Training Protocols

Certified Rejuran practitioners complete 18 hours of specialized training covering:

Environmental Sustainability

Rejuran’s manufacturer upcycles 97% of salmon byproducts from food-grade fisheries, reducing biological waste. Each batch uses 400% less water than bovine collagen production methods.